Public Joint-Stock Company "Human Stem Cells Institute"
ISKJ.ME
Price:
$70.28
Market Cap:
$5.74B
Public Joint-Stock Company 'Human Stem Cells Institute' operates as a biotech company primarily in Russia. The company engages in the drug discovery, research and development, and marketing of proprietary products and services in the field of regenerative medicine; bio-insurance; medical genetics, including reproductive genetics; gene therapy; and biopharmaceutics. It owns and operates Gemabank, a family cord blood stem cell bank in Russia and the CIS; and Reprobank, a reproductive cell and tissue bank for personal storage of reproductive cells and tissues, as well as a sperm/oocyte donation. The company also offers Neovasculgen, a gene-therapy drug for treatment of peripheral arterial disea...[Read more]
Industry
Biotechnology
IPO Date
2010-03-03
Stock Exchange
MCX
Ticker
ISKJ.ME
PE Ratio
[270.31]
ROE
[5.88%]
Current Ratio
[1.40]
Dividend Yield
[0%]
Enterprise Value
[5.84B]
Dividend History
The ROE as of December 2025 (TTM) for Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) is 5.88%
According to Public Joint-Stock Company "Human Stem Cells Institute"’s latest financial reports and current stock price. The company's current ROE is 5.88%. This represents a change of -28.45% compared to the average of 8.22% of the last 4 quarters.
Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) Historical ROE (quarterly & annually)
How has ISKJ.ME ROE performed in the past?
The mean historical ROE of Public Joint-Stock Company "Human Stem Cells Institute" over the last ten years is -18.91%. The current 5.88% ROE has changed -131.09% with respect to the historical average. Over the past ten years (40 quarters), ISKJ.ME's ROE was at its highest in in the December 2019 quarter at 93.44%. The ROE was at its lowest in in the December 2017 quarter at -162.28%.
Average
-18.91%
Median
9.24%
Minimum
-200.34%
Maximum
85.63%
Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) ROE by Quarter and Year
Discovering the peaks and valleys of Public Joint-Stock Company "Human Stem Cells Institute" ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 360.63%
Maximum Annual ROE = 85.63%
Minimum Annual Increase = -167.65%
Minimum Annual ROE = -200.34%
| Year | ROE | Change |
|---|---|---|
| 2024 | 52.76% | 56.37% |
| 2023 | 33.74% | 149.49% |
| 2022 | 13.52% | 172.97% |
| 2021 | 4.95% | -86.79% |
| 2020 | 37.50% | -56.20% |
| 2019 | 85.63% | -167.65% |
| 2018 | -126.58% | -36.82% |
| 2017 | -200.34% | 176.84% |
| 2016 | -72.37% | 303.87% |
| 2015 | -17.92% | 360.63% |
Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) Average ROE
How has ISKJ.ME ROE performed in the past?
The current ROE of Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
33.34%
5-year avg
28.49%
10-year avg
-18.91%
Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) ROE vs. Peers
How is ISKJ.ME’s ROE compared to its peers?
Public Joint-Stock Company "Human Stem Cells Institute"’s ROE is
| Company | ROE | Market cap |
|---|
Build a custom stock screener for Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Public Joint-Stock Company "Human Stem Cells Institute" using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Public Joint-Stock Company "Human Stem Cells Institute" or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Public Joint-Stock Company "Human Stem Cells Institute"'s ROE?
How is the ROE calculated for Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME)?
What is the highest ROE for Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME)?
What is the 3-year average ROE for Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME)?
What is the 5-year average ROE for Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME)?
How does the current ROE for Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) compare to its historical average?